Cellebrite DI (CLBT) Other Operating Expenses (2020 - 2025)

Cellebrite DI (CLBT) has reported Other Operating Expenses for 6 consecutive years, with $38.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Other Operating Expenses rose 8.55% year-over-year to $38.6 million; the TTM figure through Dec 2025 stood at $154.8 million (up 16.94% YoY), while the FY2025 annual figure was $154.8 million, up 23.94% from the prior year.
• Other Operating Expenses came in at $38.6 million for Q4 2025 at Cellebrite DI, down from $38.8 million in the prior quarter.
• The five-year high for Other Operating Expenses was $38.8 million in Q3 2025, with the low at -$81.3 million in Q4 2023.
• Average Other Operating Expenses over 5 years is $14.8 million, with a median of $25.8 million recorded in 2022.
• Across the five-year window, Other Operating Expenses slumped 14321.54% in 2023 and soared 389.98% in 2024, its largest moves.
• Year by year, Other Operating Expenses stood at -$49.8 million in 2021, then jumped by 101.15% to $572000.0 in 2022, then plunged by 14321.54% to -$81.3 million in 2023, then soared by 143.67% to $35.5 million in 2024, then climbed by 8.55% to $38.6 million in 2025.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $38.6 million, $38.8 million, and $38.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.